Background: The prevalence of diabetes has been proposed as a European Community Health Indicator. The prevalence of diabetes known to general practitioners (GPs) in different European countries has been investigated and the usefulness of sentinel practice networks in delivering prevalence data on diabetes has been evaluated. Methods: Patients presenting with diabetes in a 12 month period (1999/2000) to GPs in established European sentinel practice surveillance networks in eight European countries were registered. Estimates of prevalence were standardized to the 1998 European population. Results: All-age prevalence reported in the network populations was lowest in Slovenia (male 16, female 16 per 1000) and highest in Belgium (male 31, female 34). The range of estimates obtained in this study was narrower than that published by the WHO in the Health For All database. The range was further reduced by age standardization. In males aged 45 years and over, age standardized prevalence ranged from 39 (Slovenia) to 76 (Belgium) and in females from 37 (Slovenia) to 75 (Belgium). There were no consistent gender differences in national prevalence rates. Conclusions: The study demonstrates the capacity of sentinel practice networks to deliver data on the prevalence of known diabetes in persons over 45 years. National differences in prevalence are less than hitherto reported. Prevalence in Belgium measured in all ages and in 45 years and over males and females was higher than in the seven other countries.
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Diabetes mellitus is a particularly important disease because of its impact on life expectancy 1-4 and the demands it imposes on healthcare 5,6 especially with co-morbidities included. 7, 8 Furthermore there is evidence that modern western lifestyle may be contributing to increased prevalence, particularly in developing countries. [9] [10] [11] [12] [13] It is not surprising therefore that diabetes mellitus has been proposed as one of the European Community health indicators in the European Union sponsored programme on Health Monitoring. 14 There are now well-established general practice based networks monitoring the incidence and in some cases the prevalence of disease. They were established chiefly to monitor the incidence of influenza and epidemic diseases. 15, 16 These sentinel practice networks accumulate information systematically from routine consultations in primary care and some of them have long experience in monitoring diabetes. The Birmingham Diabetes Survey 17 was conducted in 10 practices who formed This is a NIVEL certified Post Print, more info at http://www.nivel.eu the initial practice monitoring group now structured as the Weekly Returns Service (WRS) of the Royal College of General Practitioners. 18 This network examined community prevalence of known diabetics (0.64% of the population surveyed in 1961) and the prevalence of impaired glucose tolerance in the remaining nondiabetic population. A further 0.69% of the cooperating patients (94% of those with glycosuria detected on a urine test strip) were found to have diabetic abnormality on glucose tolerance test. The WRS network estimated prevalence of known diabetes from general practitioner records at 1.6% in 1993. 19 The sentinel network in the Netherlands has operated since 1970 reporting continuously on core conditions, supplementing recording from time to time to include other disorders of interest. In 1990 to 1992 the network reported on the new incidence of diabetes (1.49 per 1000 Dutch national population). 20 In Portugal, sentinel practice networks have examined the prevalence, incidence and complications of diabetes and in 1993 the network reported 2.0% population prevalence and incidence increasing from 2.42 per 1000 in 1992 to 3.08 per 1000 in 1998. 21 These three national networks have a particular advantage for epidemiological research because the healthcare system involves practices caring for age-and gender-defined registered populations. In addition, healthcare delivery in these countries is largely controlled by primary care with onward referral to secondary care limited to referral from primary care. Though practice recruitment to the networks is necessarily selective, all have achieved national population representativeness by age and gender. Practice networks in Belgium 22 and France have collaborated in collecting data for diabetes quality of care initiatives. In some former eastern block countries there are continuous routines of data collection from primary care as part of the administrative infrastructure for monitoring health service activity. The prevalence of diabetes (Types I&II) known to general practitioners contributing to sentinel practice networks in European countries was investigated; first to assess the capacity of these networks to deliver such data and second, to seek for evidence of national differences. Prevalence rates for diabetes derived from hospital data are limited to those attending hospital, and rates from death certificates are limited by inconsistent entry of secondary cause details. This present study has been undertaken against a background of widely differing estimates of prevalence in European countries. 2, 23, 24 Populationbased studies reported in the Decode survey 23 based on male and female persons in the age range 39-88 years reported 3.6% known diabetics in the Netherlands, 6.4% in Denmark and 8.0% in Italy. A more intensive investigation of subjects in accordance with the WHO criteria doubled the rate in the Netherlands and Denmark. However, in contrast, in France in a population employed by Telecom (age range 17-75 years) known prevalence was 0.2% increasing only to 1.0% following investigation in accordance with the WHO criteria. 25 The Newcastle Heart Project reporting on persons 27-76 years estimated known prevalence at 2.7%. 26 A recent study in north Wales involving record searches in combined primary and secondary care data sources reported 2.19% all-age prevalence and 1.89% in persons identified from general practice records. 27 Using a modelling procedure including age adjustment to the national population in 1998 and allowing for possible under-notification of cases (particularly of Type II diabetics) these authors estimated national prevalence at 2.29%. Prevalence of both Types I and II diabetes was higher in males. A questionnaire survey of patients receiving treatment with anti-diabetic drugs identified through the total 742 Finland pharmacies in 1989 suggested 1.93% of the population were being treated for diabetes. 8
MATERIAL AND METHODS
Sentinel practice networks in Europe with information on the prevalence of diabetes (England, France, Portugal, Slovenia) and other networks (Belgium, Croatia, The Netherlands, Spain) willing to collect prevalence data were identified. The former group provided the retrospective prevalence data on diabetes for the year 1999 from practice-based information systems generated as part of routine healthcare provision. The latter group collected data prospectively during the year 2000 as diabetic patients consulted: diabetes mellitus being added to the list of conditions surveyed in the network for that year. In Spain, data were provided by three regional networks and the results consolidated. The data from Slovenia were collected as part of a routine monitoring programme for the total population. Data were collected on age, gender and management: this report is concerned solely with the prevalence of diabetes mellitus in the twelve month period of observation. The distributions of cases by age (0-24, 25-44, 45-64, 65-74, ≥75 years) and gender were examined first. Prevalence rates were calculated based on the populations under surveillance derived from the This is a NIVEL certified Post Print, more info at http://www.nivel.eu registration lists of patients in the practices surveyed (England, The Netherlands, Portugal, Slovenia, Spain), by estimation of the population from the frequency of consultations (Belgium 28 ), or from the national ratio of population to the number of general practitioners (France). For Croatia, registration data were available only for persons less than and over 65 years; the distributions within these broad groups were estimated from the national population.
Age-and gender-specific population rates were calculated. Rates for all ages and for persons 45 years and over were standardized to the European Union 15 country population for 1998 published by Eurostat. 29 Confidence intervals at 95% for the agestandardized rates were calculated by the usual method, which takes account of the size of the sentinel network populations (i.e. the samples) and the European Union population (standard population). 30 
RESULTS
Populations surveyed and the proportion of males (all ages) and persons over 65 years (males and females separately) in each of the networks are given in table 1. The national proportions of males in all countries ranged between 48.1% and 49.5% and the proportions in the populations under surveillance were broadly similar. The distributions of the surveyed populations over 65 years in most countries were similar to the national distributions; 29 in Croatia there was a strong age bias.
[ TABLE 1 ]
The numbers of diabetics identified in each network and the percentage distribution by age and gender are given in table 2. (Age/gender information was not known for 172 cases in Belgium and 135 in Spain; these cases were excluded from this analysis.) The proportion of male cases (all ages) ranged from 41.4% in Croatia to 54.1% in England. The proportions of males in the age groups 0-24 and 25-44 years exceeded the equivalent proportions in females, whereas in the age groups 65-74 and 75 years and over they were less. In the age group 45-64 years a male over female excess was evident in all countries except Croatia and Portugal. The proportion of patients aged 45 years and over exceeded 90% in most countries: lesser proportions were found in England 86.2%, Slovenia 88.0% and The Netherlands 89.8%. Prevalence rates by age and gender are reported for each network in table 3. Among persons in the age groups 0-24 and 25-44 years, rates in Belgium, England and The Netherlands were higher than those in the remaining countries. In all countries, rates in the age groups 45-64 years were much greater than those in the age group 25-44 years. Prevalence rates reported in the network populations are compared with those reported in the WHO report for 1998 (table 4 ). The range of results reported in this study is much more limited than that found in nationally matched WHO data. 31
[ TABLE 2-4]
Age-standardized prevalence rates (95% confidence intervals) are given in table 5 separately for males and females of all ages and for those aged 45 years and over. (Slovenian rates in age group 65 years and over were applied to age groups 65-74 and 75 years and over.) Rates in Belgium (male and female, all ages and age 45 years and over) are significantly greater and those in Slovenia lower than those in the other six countries. Rates in Croatia are likely overestimated because of the age bias in the population surveyed. There was no consistent relationship between male and female rates. Among persons 45 years and over male and female prevalence was broadly similar excepting England and France where male rates exceeded female.
[ TABLE 5 ]

DISCUSSION
The study of the prevalence of known diabetes in eight European countries has disclosed all-age standardized rates between 17 per 1000 (male and female) in Slovenia and 31 (male), 34 (female) in Belgium. Rates in Slovenia were particularly low in males over 65 years, though for females, age-This is a NIVEL certified Post Print, more info at http://www.nivel.eu Health: 14, 2004, nr. 1, p. 10-14 specific rates were similar to those in England. In Belgium rates were particularly high in persons over 65 years. While the study estimates show an almost twofold national variation (age over 45 years), this degree of variation is considerably less than that reported from other population-based studies, 23 especially where screening for undetected diabetes is included, and presents a challenge to the credibility of the WHO database. 31 The authors consider the prevalence of known diabetes the most practical indicator for international monitoring of diabetes, although the desirability of early diagnosis 32 is not underestimated. Acquisition of data on known diabetes is difficult but much less so than truly representative data on undiagnosed diabetes. Since most diabetics receive their medication from primary care facilities, primary care is the logical data source for such information. Panzram observed that 'statistics derived from analyses of hospital and clinic populations have proven to be particularly error prone due to inevitable referral bias. The most reliable results can be expected from prospective studies of defined cohorts recruited from general population surveys'. 2 The structure of general practice in many European countries provides such a population cohort.
Reviewing the individual national results, it is of particular interest to question if there are more diabetics in Belgium than elsewhere? The reliability of the denominator is critical: the Belgian population was estimated from consultation frequencies (all ages), in the practices, which were compared with national data. The number of general practitioners and the total number of consultations bore a similar proportionate ratio to national equivalent data, validating the estimate. There is a potential for overestimation of the numerator because patients may consult more than one doctor; it is believed that this practice is uncommon and the risk of attendant overestimation is small. Buysschaert et al. screened a selected high risk elderly population concluding that Belgium had a high prevalence of diabetes. 33 This study supports that conclusion and possible reasons should be explored in further studies. The national differences in prevalence reported here, though much less than indicated from the literature outlined in the introduction are nevertheless statistically significant and important. Life style factors influence the incidence of Type II diabetes, partly reflected by the frequency of obesity in the population. 9, 10, 12 The proportion of obese persons in countries of the European Union vary between 7 and 12% (Belgium: 9%). 34 Other factors related to nutrition and genetics are likely to provide clues whereby the increasing incidence of Type II diabetes might be checked. Two main factors bear on the interpretation of the data: sampling bias and completeness of ascertainment. In England, The Netherlands, Portugal, three countries with a long history of practicebased surveillance, the surveyed populations are well representative of the national populations by age and gender and the underlying population estimates are robust. In Spain, networks are essentially regional rather than national but the doctors operate in a list-based system. In Belgium, though network practices are probably representative of practices nationally, there are difficulties in estimating the underlying population. In France, the network population was too small to consider national representativeness. With regard to the completeness of ascertainment, distinction needs to be made between Type I and II diabetes. In some countries, direct access to specialists or to communitybased paediatricians may limit case ascertainment in primary care based information systems The gatekeeper principle, whereby access to secondary care is controlled from primary care, favours case ascertainment. In England for example, general practitioners are responsible for all prescribing and thus case ascertainment is particularly reliable. The higher proportions of diabetics under 45 years reported by the sentinel networks in England, Slovenia and The Netherlands suggests case ascertainment in children and young adults may be incomplete in other networks: the prevalence reported in those national networks probably provides the best Europe-wide estimates for young diabetics. Since persons under 45 years account for 60% of the total population but less than 15% of cases, age-standardized prevalence in the remaining countries is only marginally underestimated. The nature of general practice is such that prevalence estimates in persons aged 45 years and over are based on high levels of case ascertainment in all networks. A study of diagnosed diabetes in Dutch general practice disclosed very few false positive diagnoses. 35 With the exception of Belgium, the agestandardized prevalence in males varied between 40 and 70, and in females 45 and 77 per 1000. The maximum contribution to the calculation of agestandardized rates came from persons 45-64 years and thus the accuracy of both numerator and denominator data in this age group is critical. This study has shown the capacity of sentinel networks to deliver data on the prevalence of known diabetes. The similarity of the findings in the English sentinel network to those reported from Wales (which included general practice and hospital records) is notable. 27 The study emphasizes the importance of population representativeness in the assembly of sentinel networks. For the individual general practitioner in Europe, working in a community with an average national age distribution, these findings suggest that about 5% of those over 45 years have diabetes. Diabetes is one of many conditions in which data from primary care are essential to understanding the epidemiology. Further research should be focused on interpreting the international differences that have been demonstrated. 
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